Back to Authors

Baccarelli, Andrea

0000-0002-3436-0640

Mayo Clinic

Columbia University

Citations 3

Accelerating the Search for Interventions Aimed at Expanding the Health Span in Humans: The Role of Epidemiology
Kritchevsky, Stephen B. , Guralnik, Jack M. , Cummings, Steven R. , Salive, Marcel E. , Kuchel, George A. , Schrack, Jennifer A. , Morris, Martha Clare , Weir, David R. , Ben‐Shlomo, Yoav , Kirkland, James L. , Ferrucci, Luigi , Kirkland, James, Ferrucci, Luigi , Kritchevsky, Stephen B , Kuchel, George A , Newman, Anne B. , Baccarelli, Andrea , Murabito, Joanne M. , Espeland, Mark Andrew , Melzer, David R.

The Journals of Gerontology: Series A | November 13, 2019 | Volume: 75 | Issue: 1 | Pages: 77-86

10.1093/gerona/glz230 Get It

Abstract Background Extensive work in basic and clinical science suggests that biological mechanisms of aging are causally related to the development of disease and disability in late life. Modulation of the biological mechanisms of aging can extend both life span and health span in animal models, but translation to humans has been slow. Methods Summary of workshop proceedings from the 2018–2019 Epidemiology of Aging Workshop hosted by the Intramural Research Program at the National Institute on Aging. Results Epidemiologic studies play a vital role to progress in this field, particularly in evaluating new risk factors and measures of biologic aging that may influence health span, as well as developing relevant outcome measures that are robust and relevant for older individuals. Conclusions Appropriately designed epidemiological studies are needed to identify targets for intervention and to inform study design and sample size estimates for future clinical trials designed to promote health span.
DNA Methylation of Telomere-Related Genes and Cancer Risk
Joyce, Brian , Zheng, Yinan , Nannini, Drew R. , Zhang, Zhou , Gao, Tao , Kocherginsky, Masha , Murphy, Robert L. , Yang, Hushan , Achenbach, Chad J. , Roberts, Lewis R. , Hoxha, Mirjam , Shen, Jincheng , Vokonas, Pantel , Schwartz, Joel , Hou, Lifang , Murphy, Robert , Roberts, Lewis R , Liu, Lei , Baccarelli, Andrea , Zheng, Yinan , Hou, Lifang

Cancer Prevention Research | June 12, 2018 | Volume: 11 | Issue: 8 | Pages: 511-522

10.1158/1940-6207.capr-17-0413 Get It

Abstract Researchers hypothesized that telomere shortening facilitates carcinogenesis. Previous studies found inconsistent associations between blood leukocyte telomere length (LTL) and cancer. Epigenetic reprogramming of telomere maintenance mechanisms may help explain this inconsistency. We examined associations between DNA methylation in telomere-related genes (TRG) and cancer. We analyzed 475 participants providing 889 samples 1 to 3 times (median follow-up, 10.1 years) from 1999 to 2013 in the Normative Aging Study. All participants were cancer-free at each visit and blood leukocytes profiled using the Illumina 450K array. Of 121 participants who developed cancer, 34 had prostate cancer, 10 melanoma, 34 unknown skin malignancies, and 43 another cancer. We examined 2,651 CpGs from 80 TRGs and applied a combination of Cox and mixed models to identify CpGs prospectively associated with cancer (at FDR < 0.05). We also explored trajectories of DNA methylation, logistic regression stratified by time to diagnosis/censoring, and cross-sectional models of LTL at first blood draw. We identified 30 CpGs on 23 TRGs whose methylation was positively associated with cancer incidence (β = 1.0–6.93) and one protective CpG in MAD1L1 (β = −0.65), of which 87% were located in TRG promoters. Methylation trajectories of 21 CpGs increased in cancer cases relative to controls; at 4 to 8 years prediagnosis/censoring, 17 CpGs were positively associated with cancer. Three CpGs were cross-sectionally associated with LTL. TRG methylation may be a mechanism through which LTL dynamics reflect cancer risk. Future research should confirm these findings and explore potential mechanisms underlying these findings, including telomere maintenance and DNA repair dysfunction. Cancer Prev Res; 11(8); 511–22. ©2018 AACR.
CpGFilter: model-based CpG probe filtering with replicates for epigenome-wide association studies
Chen, Jun , Just, Allan C. , Schwartz, Joel , Hou, Lifang , Jafari, Nadereh, Sun, Zhifu , Kocher, Jean‐Pierre , Baccarelli, Andrea , Lin, Xihong , Sun, Zhifu , Hou, Lifang

Bioinformatics | October 9, 2015 | Volume: 32 | Issue: 3 | Pages: 469-471

10.1093/bioinformatics/btv577 Get It

Abstract Summary: The development of the Infinium HumanMethylation450 BeadChip enables epigenome-wide association studies at a reduced cost. One observation of the 450K data is that many CpG sites the beadchip interrogates have very large measurement errors. Including these noisy CpGs will decrease the statistical power of detecting relevant associations due to multiple testing correction. We propose to use intra-class correlation coefficient (ICC), which characterizes the relative contribution of the biological variability to the total variability, to filter CpGs when technical replicates are available. We estimate the ICC based on a linear mixed effects model by pooling all the samples instead of using the technical replicates only. An ultra-fast algorithm has been developed to address the computational complexity and CpG filtering can be completed in minutes on a desktop computer for a 450K data set of over 1000 samples. Our method is very flexible and can accommodate any replicate design. Simulations and a real data application demonstrate that our whole-sample ICC method performs better than replicate-sample ICC or variance-based method. Availability and implementation: CpGFilter is implemented in R and publicly available under CRAN via the R package ‘CpGFilter’. Contact: chen.jun2@mayo.edu or xlin@hsph.harvard.edu Supplementary information: Supplementary data are available at Bioinformatics online.